Veterinary Oxygen Therapy Market Report 2026

Veterinary Oxygen Therapy Market Overview

• Veterinary Oxygen Therapy market size has reached to $1.27 billion in 2025 • Expected to grow to $1.86 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Growth of Veterinary Oxygen Therapy Market Due to Improved Access to Veterinary Care and Advancements in Telemedicine • Market Trend: Pawprint Oxygen Introduces PureVent Pet Oxygen Mask with Advanced Tri-Vent Technology for Enhanced Veterinary Care • North America was the largest region in 2025.

What Is Covered Under Veterinary Oxygen Therapy Market?

Veterinary oxygen therapy is a medical treatment used in veterinary medicine to provide supplemental oxygen to animals experiencing respiratory distress, hypoxia (low blood oxygen levels), or other conditions affecting their ability to breathe effectively. The goal of oxygen therapy is to increase the oxygen concentration in the blood, helping vital organs function properly and supporting recovery from illness or injury. The main product types of veterinary oxygen therapy are veterinary oxygen concentrators and accessories. Accessories include a variety of components that support oxygen delivery, such as nasal cannulas, oxygen masks, humidifiers, tubing, and flow meters. The various animal types include small animals, large animals, and others. These are used in various applications such as intensive care units (ICU), homecare settings, or postoperative care, others, and also by various end-users such as veterinary hospitals, veterinary clinics, and others.

What Is The Veterinary Oxygen Therapy Market Growth Forecast?

The veterinary oxygen therapy market size is expected to see strong growth in the next few years. It will grow to $1.86 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to growth in companion animal population, rising demand for advanced intensive care services, increasing adoption of portable and homecare oxygen systems, expansion of emergency and specialty veterinary services, growing investment in veterinary critical care infrastructure. Major trends in the forecast period include rising adoption of oxygen therapy in veterinary critical care, increasing demand for portable oxygen concentrators, growing use of oxygen therapy in postoperative recovery, expansion of homecare oxygen therapy for companion animals, higher focus on respiratory disease management in animals.

Global Veterinary Oxygen Therapy Market Segmentation

1) By Product: Veterinary Oxygen Concentrator, Accessories 2) By Animal Type: Small Animals, Large Animals, Other Animal Types 3) By Application: Intensive Care Units (ICU), Homecare setting Or Postoperative Care, Other Applications 4) By End-User: Veterinary Hospitals, Veterinary Clinics, Other End-Users Subsegments: 1) By Veterinary Oxygen Concentrator: Portable Oxygen Concentrators, Stationary Oxygen Concentrators, High-Flow Oxygen Concentrators 2) By Accessories: Oxygen Masks, Oxygen Tubing, Flow Meters and Regulators, Oxygen Cages and Chambers

What Are The Drivers Of The Veterinary Oxygen Therapy Market?

The increasing trend of pet adoption is expected to propel the growth of the veterinary oxygen therapy market going forward. The increase in pet adoption can be attributed to several factors, such as social trends, urbanization, and a rise in young adults delaying parenthood. Veterinary oxygen therapy offers a critical lifeline for pets with respiratory conditions, providing pet owners peace of mind by ensuring their beloved animals receive the oxygen support needed for a faster, more comfortable recovery. For instance, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, in 2024, Canada was home to an estimated 7.2 million dogs and 8.2 million cats, making pets an integral part of more than half of Canadian households. Therefore, the increasing trend of pet adoption drives the veterinary oxygen therapy industry. Improved access to veterinary care is expected to propel the growth of the veterinary oxygen therapy market going forward. Veterinary care refers to the medical, surgical, and preventive healthcare provided to animals by trained professionals (veterinarians and veterinary nurses/technicians) to promote animal welfare, treat illness and injury, ensure public health, and support the human-animal bond. Improved access to veterinary care is increasing due to advancements in telemedicine and mobile veterinary services, making it easier for pet owners to access healthcare for their animals. Veterinary oxygen therapy enhances animal survival and recovery during critical care situations, providing veterinarians with a reliable, rapid-response treatment option that not only improves patient outcomes but also supports broader access to high-quality veterinary care by enabling clinics, especially in underserved or resource-limited areas, to manage respiratory emergencies effectively and expand the range of services they can offer. For instance, in December 2024, according to the Humane World for Animals, a US-based nonprofit organization, in 2024, that same organization expanded its efforts delivering 66,700 services to over 16,200 pets directly and supporting another 35,200 through partners. Therefore, improved access to veterinary care is driving the growth of the veterinary oxygen therapy industry.

Key Players In The Global Veterinary Oxygen Therapy Market

Major companies operating in the veterinary oxygen therapy market are Jiangsu Yuyue Medical Equipment & Supply Co. Ltd., CAIRE Inc., Veterinary Specialty Center, Burtons Medical Equipment Ltd., Longfian Scitech Co. Ltd., CalOx Inc., Shinova Systems Co. Ltd., Vetland Animal Health Services Private Ltd., Airnetic LLC, RWD Life Science Co. Ltd., AEOLUS International Pet Products LLC, Pawprint Oxygen, New Veterinary Equipment, Avante Animal Health Inc., Vetamac Inc., Kalstein, Keyhub, Shenyang Aerti Tech, VetFlex, BMV Animal Technology, Contec Medical Systems, Jorgensen Laboratories, ON2 Solutions, Intensovet

Global Veterinary Oxygen Therapy Market Trends and Insights

Major companies in the veterinary oxygen therapy market are focusing on technological advancements, such as tri-vent technology, to improve oxygen delivery and management for animals, enhance ease of use for veterinarians, and ensure better treatment outcomes for pets and livestock. Tri-vent technology features a design with three vents to optimize airflow, prevent carbon dioxide buildup, and improve safety by facilitating more effective oxygen delivery and exhalation management. For instance, in April 2023, Pawprint Oxygen, a US-based oxygen solutions company, introduced the PureVent Pet Oxygen Mask, a specialized device designed for pets in respiratory distress. The mask features a triangular ergonomic shape that improves oxygen delivery while minimizing harmful gas rebreathing. This design is particularly effective for pets suffering from conditions such as congestive heart failure (CHF), asthma, and laryngeal paralysis. The tri-vent system, with three strategically placed vents, allows exhaled carbon dioxide (CO2) to escape without mixing with incoming oxygen, reportedly reducing CO2 rebreathing by up to 80%. The PureVent Pet Oxygen Mask represents a significant advancement in veterinary care, offering a safer and more efficient solution for administering oxygen to pets while ensuring their comfort and safety.

Regional Outlook

North America was the largest region in the veterinary oxygen therapy market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Oxygen Therapy Market?

The veterinary oxygen therapy market consists of revenues earned by entities by providing services such as high-flow oxygen therapy, hyperbaric oxygen therapy, oxygen administration during anesthesia, standard oxygen therapy and emergency oxygen therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary oxygen therapy market also includes sales of nasal catheter, oxygen mask, oxygen chamber, oxygen tent and pure line oxygen concentrators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.